HPQ
37
2
L
65
-4
RRC
59
-4
KSS
54
2
EXPD
35
-2
APA
48
-5
PPL
60
-2
DLTR
64
-2
CCI
33
-5
MRK
56
-4
CPB
39
4
LEG
58
-4
EMC
54
-2
DHR
64
-4
AZO
43
-5
SLB
42
-4
KHC
29
2
AEP
59
-5
MPC
41
-8
PVH
42
-2
HPQ
37
2
L
65
-4
RRC
59
-4
KSS
54
2
EXPD
35
-2
APA
48
-5
PPL
60
-2
DLTR
64
-2
CCI
33
-5
MRK
56
-4
CPB
39
4
LEG
58
-4
EMC
54
-2
DHR
64
-4
AZO
43
-5
SLB
42
-4
KHC
29
2
AEP
59
-5
MPC
41
-8
PVH
42
-2
Financhill
Back

Biomea Fusion, Inc. Vs. Nektar Therapeutics Industry Stock Comparison

Sell
44

BMEA
Biomea Fusion, Inc.

Last Price:
$1.33
Seasonality Move:
8.34%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$44.64
Seasonality Move:
11.58%
Sell
44
Biomea Fusion, Inc. (BMEA) is a Sell

Is Biomea Fusion, Inc. a Buy, Sell or Hold?

  • The current Biomea Fusion, Inc. [BMEA] share price is $1.37. The Score for BMEA is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • BMEA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BMEA Stock Price Chart

What is Biomea Fusion, Inc.'s stock price today?

  • The Biomea Fusion, Inc. share price today is $1.37
    The current trend is relatively stagnant and BMEA is experiencing buying pressure, which is a positive indicator for future bullish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

BMEA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 54.24 Buy
Chaikin Money Flow: 870120 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.04 - 1.38) Buy
Bollinger Bands (100): (1.28 - 1.94) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

BMEA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.39 Sell
20-day SMA: 1.19 Buy
50-day SMA: 1.35 Buy
200-day SMA: 1.83 Sell
8-day EMA: 1.35 Buy
20-day EMA: 1.29 Buy
50-day EMA: 1.38 Sell
200-day EMA: 2.43 Sell

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

Biomea Fusion, Inc. Earnings Growth & BMEA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.39 per share, and an increase next year of $0.46 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Biomea Fusion, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):